Scholarlink

<p>Objectives: We aimed to understand tobacco use and treatment patterns among adults starting care in a Chennai HIV clinic. Methods: Cross-sectional survey of adults initiating HIV care with biochemical verification of tobacco exposure. Results: Among 154 adult patients (10/2019-12/2021) initiating HIV care, 37.7% (<i>n</i> = 58) self-reported current tobacco use (13.6% [<i>n</i> = 21] smoking, 17.5% [<i>n</i> = 27] smokeless tobacco [SLT], 6.5% [<i>n</i> = 10] dual use) and 7.8% (<i>n</i> = 12) reported former use (5.8% [<i>n</i> = 9] smoking, 1.3% [<i>n</i> = 2] SLT, 0.6% [<i>n</i> = 1] dual), none reported using cessation medications, two reported counseling. Cotinine levels indicating current use varied by tobacco product (smoking: 66.7% had cotinine ≥ 50ng/ml; SLT: 70.4%; dual: 80.0%, no current tobacco: 44.8%, <i>p</i> = 0.02). Conclusion: Smoking and SLT use are common and underreported and evidence-based cessation treatment use was rare prior to HIV care initiation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of tobacco use in a cross-sectional survey of people initiating HIV care in a Chennai clinic

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • S. Poongulali,
  • Nancy A. Rigotti,
  • N. Kumarasamy,
  • Catherine Nagawa,
  • B. Faith,
  • Gina Rae Kruse

摘要

Objectives: We aimed to understand tobacco use and treatment patterns among adults starting care in a Chennai HIV clinic. Methods: Cross-sectional survey of adults initiating HIV care with biochemical verification of tobacco exposure. Results: Among 154 adult patients (10/2019-12/2021) initiating HIV care, 37.7% (n = 58) self-reported current tobacco use (13.6% [n = 21] smoking, 17.5% [n = 27] smokeless tobacco [SLT], 6.5% [n = 10] dual use) and 7.8% (n = 12) reported former use (5.8% [n = 9] smoking, 1.3% [n = 2] SLT, 0.6% [n = 1] dual), none reported using cessation medications, two reported counseling. Cotinine levels indicating current use varied by tobacco product (smoking: 66.7% had cotinine ≥ 50ng/ml; SLT: 70.4%; dual: 80.0%, no current tobacco: 44.8%, p = 0.02). Conclusion: Smoking and SLT use are common and underreported and evidence-based cessation treatment use was rare prior to HIV care initiation.